Showing results (211-220 of 292) with videos related to

Sort By:
Pageof 30
Journal of the Pediatric Infectious Diseases Society|February 26, 2014
Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of AgeScott A Halperin, Yaela Baine, Joseph B Domachowske, et al.
The Journal of Infection|January 29, 2018
Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant womenMonica Fabbrini, Fabio Rigat, Giovanna Tuscano, et al.
Pediatrics|July 20, 2011
Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 monthsDanuta M Skowronski, Travis S Hottes, Mei Chong, et al.
Plos One|September 9, 2025
Gaps in immunization coverage at school entry and after two years of school attendance among immigrant and refugee children in Ontario, CanadaSarah E Wilson, Catharine Chambers, Andrew S Wilton, et al.
Vaccines|December 23, 2022
Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis InitiativeBahaa Abu-Raya, Kevin Forsyth, Scott A Halperin, et al.
The Lancet. HIV|August 7, 2026
Safety and immunogenicity of one or two doses of the rVSVΔG-ZEBOV-GP Ebola virus vaccine in adults and adolescents living with HIV: a phase 2, multicentre, double-blind, randomised, placebo-controlled trialCécile Tremblay, Innocent Valea, Birahim Pierre Ndiaye, et al.
Vaccine|October 2, 2021
Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysisBahaa Abu-Raya, Kirsten Maertens, Flor M Munoz, et al.
Clinical and Vaccine Immunology : CVI|May 24, 2013
Elevated inflammatory mediators in adults with oculorespiratory syndrome following influenza immunization: a public health agency of Canada/Canadian Institutes of Health Research Influenza Research Network StudyMona Al-Dabbagh, Keswadee Lapphra, David W Scheifele, et al.
Vaccine|January 23, 2026
Safety and immunogenicity of a 25-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive healthy adults: Results from 2 randomised, controlled clinical trialsJoanne M Langley, Manish Sadarangani, Christian Ockenhouse, et al.
Vaccine|March 6, 2018
Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised studyClare L Cutland, Terry Nolan, Scott A Halperin, et al.
Pageof 30